LISA STEPHENSON: Open Payments
NPI 1194909697 · HALFMOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 9 payments from 8 companies in 2025. Trend: 2023 $693 · 2024 $479 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $219 |
| Madrigal Pharmaceuticals | 1 | $135 |
| UCB, Inc. | 1 | $128 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $124 |
| Novo Nordisk Inc | 1 | $123 |
| ABIOMED | 1 | $93 |
| Eisai Inc. | 1 | $83 |
| ALK-Abello, Inc | 1 | $56 |
Products named: REZDIFFRA, WaveWriter Alpha Prime 16, Rystiggo, Wegovy, General - Pain Management, Leqembi.
Industry payments across NY — which companies pay providers there.
